Business
Movano Health Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
Movano Health (Nasdaq: MOVE)(the "Company") announced today that it received a notice (the "Notice") from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") indicating that because the Company had not yet filed its Form 10-Q for the quarterly period ended June 30, 2025 (the "Form 10-Q"), the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Filing Requirement") requiring Nasdaq-listed companies to timely file all periodic financial reports with the
About this update from Corvex, Inc.
[{"type":"text","content":"PLEASANTON, Calif., Aug. 22, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE)(the "Company") announced today that it received a notice (the "Notice") from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") indicating that because the Company had not yet filed its Form 10-Q for the quarterly period ended June 30, 2025 (the "Form 10-Q"), the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Filing Requirement") requiring Nasdaq-listed companies to timely file all periodic financial reports with the Securities and Exchange Commission (the "SEC"). The Form 10-Q was due on August 14, 2025.","length":699,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/Movano)","displaySize":"","headline":null,"caption":"(PRNewsfoto/Movano)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":94,"url":"https://media.zenfs.com/en/prnewswire.com/c36c884c653f57e00c1b69adf57b4c0e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/6AKWiouQyImH3nvexOa55Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE2NjtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/c36c884c653f57e00c1b69adf57b4c0e","width":400,"height":94}},"href":"https://mma.prnewswire.com/media/1718078/Movano_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The Company appealed its previously announced delisting determination at a hearing with the Nasdaq Hearing Panel (the "Panel") on August 19, 2025 during which the Company submitted a plan to regain compliance with the Filing Requirement and the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Compliance Plan"). As part of the Compliance Plan and as previously disclosed, on August 13, 2025, the Company engaged RBSM LLP ("RBSM") as the Company's new independent registered public accounting firm for the fiscal year ending December 31, 2025 and interim periods. The Company is awaiting the determination of the Panel. There can be no assurance that the Panel will grant the Company's request for a stay of the suspension of the Company's securities from trading on the Nasdaq Capital Market to allow for the Company to execute its Compliance Plan or that the Company will be able to regain compliance and thereafter maint...